Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,118 | 8,320 | 18,207 | 32,363 | 49,046 |
| TOTAL | $8,013 | $9,670 | $20,613 | $37,537 | $51,232 |
| Non-Current Assets | |||||
| PPE Net | 120 | 324 | 380 | 495 | 678 |
| Other Non-Current Assets | 5,695 | 5,914 | 6,136 | 258 | 512 |
| TOTAL | $5,815 | $6,238 | $6,516 | $753 | $1,190 |
| Total Assets | $13,828 | $15,908 | $27,129 | $38,290 | $52,422 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,353 | 16,811 | 15,795 | 15,452 | 13,704 |
| Other current liabilities | 4,142 | N/A | N/A | N/A | N/A |
| TOTAL | $21,922 | $17,984 | $16,600 | $16,006 | $14,540 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 28,095 | 29,161 | 27,274 | 21,737 | 23,617 |
| TOTAL | $28,095 | $29,161 | $27,274 | $21,737 | $23,617 |
| Total Liabilities | $50,017 | $47,145 | $43,874 | $37,743 | $38,157 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,846 | 58,792 | 58,722 | 58,418 | 58,401 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -545,646 | -535,862 | -520,084 | -501,373 | -486,039 |
| TOTAL | $-36,189 | $-31,237 | $-16,745 | $547 | $14,265 |
| Total Liabilities And Equity | $13,828 | $15,908 | $27,129 | $38,290 | $52,422 |